Project Grant F32DA063284

Award Date 9/25/25
Completion Date Not listed
Dollars Obligated $76K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to determine the mechanisms by which cocaine affects striatal circuit activity and facilitates cocaine seeking and taking behaviors. The $226,295 award, with a performance period from August 15, 2024 to May 31, 2027, will enable the University of Texas at Austin to: 1) investigate the role of striatal enkephalin in cocaine-induced...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $438,750 to the University of California, San Diego (UCSD) to investigate pre-existing differences in GABAergic and glutamatergic transmission within the central amygdala and their potential contribution to individual differences in cocaine addiction susceptibility. The study aims to characterize and compare basal GABAergic and...
This $234,000 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research at Oregon Health & Science University (OHSU) to investigate rapid protein translation in nucleus accumbens neurons in response to a cocaine-associated cue. The goal is to use translating ribosome affinity purification and RNA sequencing (TRAP-seq) to identify mRNAs that are actively translating during re-exposure to cocaine...
The University of Pennsylvania received a $527,837 Project Grant award from the National Institute on Drug Abuse, part of the Department of Health and Human Services, to study altered midbrain GABAergic circuitry and its role in driving greater cocaine self-administration. Specifically, the researchers will characterize the functional state of midbrain GABAergic circuitry and the disposition of the KCC2 potassium-chloride cotransporter during cocaine self-administration, extinction, and...
This Project Grant award of $1,159,396 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research at Vanderbilt University on the molecular and epigenetic mechanisms underlying how cocaine exposure activates specific neuronal ensembles in the nucleus accumbens and how these ensembles change over time to drive addiction-related behaviors. The research aims to use innovative techniques like single-nucleus RNA sequencing and...
This federal Project Grant award, with ID R01DA060250, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,447,919 award, granted on May 1, 2025, supports research conducted by Pennsylvania State University's Milton S. Hershey Medical Center to investigate the "need-state hypothesis" of cocaine addiction. The research aims to use an animal model to track the development of cocaine addiction, identify the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $121,323 to the University of North Carolina at Chapel Hill to investigate the structural and functional responses of nucleus accumbens microglia following long-access cocaine self-administration in male and female rats. The key research aims are to: 1) Explore morphological responses of accumbens microglia and evidence of astrocyte membrane...
This $149,284 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to Vanderbilt University will fund research to understand how chronic cocaine use disrupts the neural processing of aversive, non-drug stimuli in the brain. The study aims to define the precise temporal parameters under which dopamine release modulates the activity of genetically-defined neuron populations in the nucleus accumbens, both at baseline and in...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,996,709.00 to the Trustees of Indiana University, doing business as Indiana University Indianapolis, for a project titled "Involvement of Cortical Excitatory Projections in Cocaine Addiction." The project aims to investigate the role of cortical pyramidal neurons in the supplementary motor cortex and their impact on glutamate...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to characterize the functions of several transcript variants of the DRD3 gene, which encodes the dopamine D3 receptor, and their roles in regulating cocaine-seeking and taking behavior. The $189,644 award to Wake Forest University Health Sciences will fund two phases of research. In the initial R21 phase, the researchers...

SPECIFICITY AND STABILITY OF COCAINE ENSEMBLES - PROJECT SUMMARY AND ABSTRACT. A KEY FEATURE OF COCAINE USE DISORDER IS AN INCREASE IN DRUG TAKING AND SEEKING THAT DEVELOPS OVER AN INDIVIDUAL'S DRUG-USE HISTORY. TO THIS END, A LARGE AMOUNT OF WORK HAS BEEN FOCUSED ON UNDERSTANDING HOW PLASTICITY IN REWARD-RELATED BRAIN REGIONS STRENGTHENS CIRCUITS THAT DRIVE MOTIVATION. HOWEVER, IN HUMANS AND ANIMAL MODELS, WHILE CHRONIC DRUG USE INCREASES DRUG SEEKING, IT SIMULTANEOUSLY REDUCES MOTIVATION FOR ALTERNATIVE REINFORCERS SUCH AS SUCROSE. THE GOAL OF THIS PROPOSAL IS TO UNDERSTAND THE NEURAL MECHANISM BY WHICH COCAINE SELF-ADMINISTRATION DIFFERENTIALLY ALTERS THE NEURAL ENCODING DRUG AND NON-DRUG REINFORCERS. THE NUCLEUS ACCUMBENS (NAC) IS A KEY REGION THAT CAUSALLY MEDIATES REWARD ENCODING FOR BOTH DRUG AND NON-DRUG REWARDS. THIS REGION IS COMPRISED OF MEDIUM SPINY NEURONS (MSNS) THAT ARE LARGELY SEGREGATED INTO TWO NON-OVERLAPPING POPULATIONS BASED ON THEIR EXPRESSIONS OF D1 AND D2 TYPE DOPAMINE RECEPTORS. D1 MSNS, WHICH SPECIFICALLY DRIVE DRUG SEEKING, ARE ACTIVATED AT THE POPULATION LEVEL BY BOTH DRUGS AND SUCROSE AND UNDERGO ROBUST DRUG-INDUCED PLASTICITY FOLLOWING REPEATED COCAINE USE. TWO QUESTIONS GUIDE OUR RESEARCH IN THIS AREA: 1. DO COCAINE AND SUCROSE ACTIVATE DIFFERENT POPULATIONS OF D1 MSNS? AND 2. DOES REPEATED COCAINE USE DIFFERENTIALLY AFFECT THE ABILITY OF COCAINE OR SUCROSE TO INCREASE D1 MSN ACTIVITY IN THE NAC? USING CELLULAR RESOLUTION IMAGING IN AWAKE AND BEHAVING ANIMALS WITH MICROENDOSCOPES, WE WILL RECORD SINGLE-CELL NEURAL ACTIVITY IN THE SAME ANIMALS IN RESPONSE TO SUCROSE AND COCAINE AND DETERMINE HOW COCAINE SELF-ADMINISTRATION ALTERS THE DYNAMICS OF EACH ENSEMBLE OVER TIME. WE HYPOTHESIZE THAT 1. COCAINE AND SUCROSE RECRUIT NON-OVERLAPPING NEURONAL POPULATIONS, AND 2. COCAINE SELF-ADMINISTRATION INCREASES THE ABILITY OF COCAINE AND DECREASES THE ABILITY OF SUCROSE TO INCREASE D1 MSN ACTIVITY. THE TRAINING PLAN INCLUDES A MENTORING TEAM LED BY ERIN CALIPARI, PHD (SPONSOR) WITH COLLABORATORS BRAD GRUETER, PHD, THILO WOMELSDORF, PHD, AND EDWARD NIEH, PHD. THIS TEAM WILL PROVIDE STRONG TRAINING IN THE USE OF CELLULAR RESOLUTION IMAGING IN AWAKE AND BEHAVING ANIMALS AND COMPUTATIONAL ANALYSES TO UNDERSTAND THE RELATION OF COMPLEX ACTIVITY DYNAMICS IN THE BRAIN AND IN BEHAVIOR. THE TRAINING PLAN WAS SPECIFICALLY CRAFTED TO BUILD UPON DR. BRADLEY BARTH'S STRONG FOUNDATION OF COMPUTATIONAL MODELING IN PERIPHERAL TISSUES TO BRING HIS TRAINING INTO THE ADDICTION FIELD. TOGETHER THIS PROJECT WILL ANSWER A FUNDAMENTAL QUESTION IN THE ADDICTION FIELD, WHILE ALSO PROVIDING TRAINING TO HELP DR. BARTH BECOME AN EXPERT IN THE NEURAL DYSFUNCTION THAT OCCURS AS A RESULT OF CHRONIC DRUG USE.

Posted 3/26/25, 12:00 AM